Dusseldorf/Tel Aviv/Zurich, 20 December 2007 - SHL Telemedicine Ltd. (SWX:SHLTN), a leading provider and developer of advanced personal telemedicine solutions, is pleased to announce that Debeka, the biggest private health insurance company in Germany, and PHTS Telemedizin, SHL's wholly owned German subsidiary, have signed an agreement to continue and expand their co-operation for a long-term.

PHTS Telemedizin to provide telemedicine services to AOK Rheinland/Hamburg through telemedicine net established in Cologne

Capital gain, net of taxes of around USD 35-40 million expected from the sale.
SHL received USD 110 million as upfront cash consideration and debt assumption. In addition, SHL will participate on a revenue sharing and royalty basis for up to 9 years in revenues of Raytel's current services and certain future services to be introduced in North America for which certain minimum payments will be made pending achievement
of agreed upon milestones.

Transaction with Philips approved by SHL shareholders. SHL is to receive around USD 110 million as upfront cash consideration and debt
assumption.

Closing of transaction with Philips has been scheduled for November 30th

Prof. Dr. med Klaus Pethig is a renowned expert in cardiac catheter treatments and cardiological intensive care and is currently the head of the cardiological department of the Evangelische Krankhaus Hamm.

of SHL’s Raytel Cardiac Services into Philips.
Tel Aviv/Zurich, 30 October 2007 - SHL Telemedicine Ltd. (SWX: SHLTN), a leading provider and developer of advanced personal telemedicine solutions, announces that it has been advised by the Pre merger Notification Office of the US Federal Trade Commission that early termination of the U.S. Antitrust Waiting Period has been granted thereby clearing the sale of Raytel Cardiac Services and other ancillary operations comprising SHL's US cardiac monitoring activities to Royal Philips Electronics (NYSE:PHG, AEX:PHI).

regarding transaction with Philips on 27 November 2007

including the distribution by Philips of SHL telemedicine products in North America

SHL Telemedicine's results for Q2 in line with expectations. SHL expects to announce significant transaction regarding its US business in coming days.

Tel Aviv/Zurich, 24 September 2007 - SHL Telemedicine Ltd. (SWX: SHLTN), a leading provider and developer of advanced personal telemedicine solutions, will now publish its half-year results on 1 October 2007.

ON NEW STATE-OF-THE ARTWIRELESS
First in a family of unique devices to assist physicians in diagnosing and managing cardiac arrhythmias

Due to the negotiations for the possible significant transaction in SHL's US business SHL Telemedicine will now report HY results in mid September 2007

for Market Leadership in the cardiac monitoring and diagnostic
services market

Patients suffering from chronic congestive heart failure, depending on their disease pattern, are receiving a SHL advanced telemedicine system for home use that transmits their vital signs and other important parameters to the medical monitor centre of PHTS Telemedizin.

A new member of Medical Advisory Board of PHTS Telemedizin. Prof. Nienaber holds the chair of cardiology at the University of Rostock and has been the head of the cardiological clinic for the last seven years.

SHL Telemedicine in discussions for transaction in the U.S.

PHTS Telemedizin, through its monitoring centre based in Dusseldorf, will provide these patients suffering from chronic heart illnesses improved care around the clock.

with EBITDA of USD 2.2 million.
Operations in Germany continued to progress with additional health insurers and an integrated telemedicine network in Cologne adopting PHTS's Telemedicine solutions.

improving the care for people suffering from chronic heart illness
This novel approach integrates family doctors, medical specialists, standard city hospitals, rehabilitation centers and the Heart Center of the Universitätsklinikum in Cologne in a trend-setting contract for integrated care.

with BKK ESSANELLE and BKK Merck. The Germany wide health insurance company BKK ESSANELLE attends for approximately 400,000 insured. BKK ESSANELLE covers employees of numerous well-known companies from the chemical industries, biotechnology and mechanical engineering sectors such as the Essanelle Hair product Group, Henkel, Schering, MAN and Rhine metal.

-  EBITDA up significantly to USD 12.2. EBIT up by approximately 300% to USD 5.0 million; Net Income from continuing operations.

launches by SHL.
"Cardio Sen'C" the first personal cellular- digital 12 lead ECG transmitter